Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > 1St quarter BTD

<< Previous

Bullboard Posts

Next >>

Comment by Eoganachton Nov 29, 2023 8:36pm

286 Views

Post# 35760040

RE:RE:RE:RE:1St quarter BTD

I don't know if the FDA required them - but they did allow them. For all I know it's part of the consultation process we don't usually hear about. Theralase is new at this and may be taking full advantage of available FDA guidance before they submit the live BTD application. They need to get this right.